Sandra K Stolz-Dunn

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Aventis Holdings, Inc., Aventis Pharmaceuticals Inc., Hoechst Marion Roussel. Active years: 1998-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandra K Stolz-Dunn. Retrieved from https://idiyas.com/inventor/sandra-k-stolz-dunn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 50.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

1 out of 3

Aventis Holdings, Inc.

patents

1 out of 207

Aventis Pharmaceuticals Inc.

patents

1 out of 236

Hoechst Marion Roussel

patents

4. 1 out of 194

Merrell Pharmaceuticals, Inc.

patents

5. 1 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

patents

where one patent can have more than one assignee

Years Active: 1998-2008

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7332607 - Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol (2008-02-19),

2. 6713627 - Processes for the preparation of (R)-&agr;-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol (2004-03-30),

3. 5959111 - Process for preparing 6-0-monoesters of castanospermine (1999-09-28),

4. 5723624 - Process for the preparation of (1998-03-03),

Title: The Innovative Contributions of Sandra K Stolz-Dunn

Introduction: Sandra K Stolz-Dunn is a notable inventor based in Midland, Michigan, recognized for her significant contributions to the field of pharmaceutical chemistry. With a portfolio of four patents, her work reflects a commitment to innovation and advancing therapeutic processes.

Latest Patents: Stolz-Dunn's latest patents focus on the development of processes for the preparation of a specific compound: (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol. These patents detail various methodologies for synthesizing this compound, providing important insights and approaches for its preparation, which is valuable for potential pharmaceutical applications.

Career Highlights: Throughout her career, Stolz-Dunn has worked with prestigious companies such as Merrell Pharmaceuticals and Hoechst Marion Roussel. Her experiences in these firms have greatly influenced her inventive journey, allowing her to hone her skills and knowledge in the pharmaceutical sector.

Collaborations: Stolz-Dunn has collaborated with notable colleagues, including David H Louks and Christian T Goralski. These professional relationships have fostered an environment of shared knowledge and innovation, enhancing the impact of her work.

Conclusion: Sandra K Stolz-Dunn exemplifies the spirit of innovation within the pharmaceutical field. Through her patents and collaborations, she continues to contribute to the advancement of new therapeutic solutions, solidifying her role as a significant inventor in her area of expertise.

Profile summary based on public USPTO records.